AI

More Articles

Baozun Announces First Quarter 2024 Unaudited Financial Results

SHANGHAI,May 28,2024-- Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun",the "Company" or the "Group"),a leading brand e-commerce solution provider and digital commerce

May 30, 2024

Milliken & Company Recognized as one of the Top 100 Global Most Loved Workplaces in 2024

SPARTANBURG,S.C.,May 28,2024-- Diversified global manufacturer Milliken & Company has been recognized as one of the 2024 Top 100 Global Most Loved Workplaces,an annual list curated byNewsweekin c

May 30, 2024

TraceLink and RSM Announce a New Strategic Business Alliance to Digitalize the End-to-End Healthcare and Life Sciences Supply Chain

Forging a New Era in Health and Life Sciences Digitalization BOSTON,May 28,2024-- In a strategic alliance poised to accelerate the digital transformation of the global Healthcare and Life Sciences (H

May 30, 2024

Tencent Deploys AI to Help Researchers Decipher Hidden Meanings in Oracle Bone Scripts

Online research platform Oracle Bones Corpus welcomes contributions from researchers and enthusiasts SHENZHEN,China,May 28,2024-- Tencent(00700.HK) today announced the launch of Oracle Bones Corpus (殷

May 30, 2024

Japan: Demonstrating Global Leadership in Pioneering Innovative Energy Technologies at the Japan Energy Summit & Exhibition

TOKYO,May 29,2024-- Japan\'s energy landscape is rapidly evolving,with a spotlight on hydrogen. Once dominant,"grey hydrogen" faces a decline as Japan pivots towards greener alternatives,emb

May 30, 2024

Trip.com Group Signs Strategic Agreements with Major Southeast Asian Hospitality Brands

SINGAPORE,May 29,2024-- Trip.com Group,a global leading travel services provider,has signed two strategic Memorandum of Understanding (MoUs) with leading hospitality brands in Southeast Asia,reinforc

May 30, 2024

Rege Nephro CO., Ltd. Announces Patient Enrollment for Phase II Clinical Trial of Tamibarotene for ADPKD

KYOTO,Japan,May 28,2024-- Rege Nephro CO.,Ltd. (https://www.regenephro.co.jp/en) has announced that patient enrollment began in April for the second stage of its Phase II clinical trial of tamibarote

May 30, 2024

2024 Wenzhou International Design Biennale Announces Call for Entry

WENZHOU,China,May 29,2024-- 2024 Wenzhou International Design Biennale is calling for entry. Welcome all professional designers and young design students to participate. There is no registration fee a

May 30, 2024

INFINIQ Unveils HEIDI AI Integrated Monitoring Solutions at ATxSG CommunicAsia 2024

SINGAPORE,May 29,2024-- Leading AI platform specialist,INFINIQ,is set to debut its HEIDI AI integrated monitoring solution lineup at ATxSG CommunicAsia 2024,the premier IT exhibition in the Asia-Pacif

May 30, 2024

The European Patent Office, The world's most powerful permanent magnet: Japanese inventor selected as finalist for the European Inventor Award 2024

MUNICH,May 29,2024-- Magnets are all around us,they drive a wide array of modern technologies and exist in one way or another in almost every field on Earth. Permanent neodymium magnets are found nowa

May 30, 2024

JOYY Reports First Quarter 2024 Financial Results: Net Profit up 34.8% Year Over Year, BIGO Sustains Revenue Growth

SINGAPORE,May 29,2024-- JOYY Inc. (NASDAQ: YY) ("JOYY" or the "Company"),a global leading technology company,announced its unaudited financial results for the first quarter of 202

May 30, 2024

Veritas Genetics at the forefront of genomic screening with new studies presented at the European Society of Human Genetics Conference - ESHG 2024

Veritas will present two pioneering studies at the European Society of Human Genetics Conference,in Berlin from June 1 to June 4. With a focus on elective genomic screening and newborn genomic screen

May 30, 2024

1 ... 73 74 75 76 77

Singapore Technology Information: Your Source for Tech, AI, Aerospace, Biotech News

Singapore Technology Information is an advanced technology news portal. Committed to reporting on the latest developments in technology, artificial intelligence, biotechnology, data and other fields.